Philogen S.p.a.
Clinical trials sponsored by Philogen S.p.a., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug aims to reignite immune attack on Hard-to-Treat cancers Results expected Dec 2026 (estimated)